Corient Private Wealth LLC Grows Stake in HCA Healthcare, Inc. $HCA

Corient Private Wealth LLC raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 40,554 shares of the company’s stock after buying an additional 1,856 shares during the period. Corient Private Wealth LLC’s holdings in HCA Healthcare were worth $15,536,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Saudi Central Bank acquired a new position in HCA Healthcare in the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new position in shares of HCA Healthcare in the first quarter worth about $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare during the 2nd quarter valued at about $27,000. Chung Wu Investment Group LLC purchased a new position in HCA Healthcare in the 2nd quarter worth approximately $27,000. Finally, Clearstead Trust LLC grew its position in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 1.1%

Shares of NYSE HCA opened at $466.70 on Friday. The stock has a fifty day simple moving average of $468.96 and a 200-day simple moving average of $416.17. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $520.00. The stock has a market capitalization of $106.50 billion, a PE ratio of 18.04, a PEG ratio of 1.39 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the previous year, the company posted $4.90 EPS. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Bank of America raised their price objective on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. KeyCorp increased their price target on shares of HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a research note on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $476.74.

Insider Activity

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.